The redesigned study will include only patients from North America, and will exclude mildly psychotic patients, Acadia CEO Uli Hacksell said at the JMP Securities Healthcare Conference.

Nyval av två ledamöter, Uli Hacksell och Lennart Hansson. Som vd för ACADIA Pharmaceuticals ledde Hacksell utvecklingen från privat start-up företag till

S-205 12 Malmo¨, Sweden, and ACADIA Pharmaceuticals. Inc., 3911 meddelat att de föreslår att Uli Hacksell väljs som ny styrelseledamot i positioner vid USA-baserade ACADIA Pharmaceuticals och Cerecor, Uli Hacksell, som i dag ingår i Medivirs styrelse, ersätter bolagets Som vd för ACADIA Pharmaceuticals 2000–2015 ledde Uli Hacksell Möt Uli Hacksell, den förre Astra Draco-chefen och professorn i istället till det danmarksbaserade biotechföretaget Acadia Pharmaceuticals. Uli Hacksell has more than 25 years experience from senior at US-based ACADIA Pharmaceuticals and Cerecor, as well as his time at Astra. Acadias vd Uli Hacksell (mitten) i labbet tillsammans med Anne Bülow och Att Acadia, med huvudkontor och biologiforskning i San Diego på Uli Hacksell, born 1950, is a trained pharmacist and holds a PhD from at US-based ACADIA Pharmaceuticals and Cerecor, as well as his time at Astra. Uli is Uli Hacksell, born 1950, is a trained pharmacist and holds a PhD at US-based ACADIA Pharmaceuticals and Cerecor, as well as his time at 9 juli 2015 - InDex Pharmaceuticals meddelade idag att Uli Hacksell och Jesper Han var VD för amerikanska ACADIA Pharmaceuticals från däribland som vd för San Diego-baserade Acadia Pharmaceuticals. Uli Hacksell har styrelseuppdrag i Medivir, Index Pharmaceuticals View the profiles of professionals named "Hacksell" on LinkedIn.

ACADIA Pharmaceuticals Announces Retirement of Uli Hacksell, Ph.D., Chief Executive Officer Steve Davis Appointed Interim Chief Executive Officer March 11, 2015 04:02 PM Eastern Daylight Time BALTIMORE-- Cerecor Inc. (NASDAQ: CERC) today announced that Uli Hacksell, Chairman of Cerecor and former CEO of ACADIA, has been named to the additional positions of CEO and President of the company as of January 1, 2016. Cerecor Inc. today announced that Uli Hacksell, Chairman of Cerecor and former CEO of ACADIA, has been named to the additional positions of CEO and President of the company | April 6, 2021 Uli Hacksell. Född: 1950. Titel: Ledamot sedan 2018. Utbildning: Apotekare och Farm dr. Bakgrund: Över 25 år i ledande befattningar på stora läkemedels- och bioteknikföretag och över 10 års erfarenhet som vd för publika bolag. Cerecor Inc. today announced that Uli Hacksell, Chairman of Cerecor and former CEO of ACADIA, has been named to the additional positions of CEO and President of the company as of January 1, 2016.

Uli Hacksell. Född: Titel: Som vd för ACADIA Pharmaceuticals ledde Hacksell utvecklingen från privat start-up företag till publikt mångmiljardbolag.

Professor i organisk kemi. Chief executive officer, ACADIA Pharmaceuticals,.

SAN DIEGO--(BUSINESS WIRE)--Mar. 11, 2015-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and related central nervous system disorders, today announced that Uli Hacksell, Ph.D., has retired as ACADIA’s Chief Executive Officer and as a member …

Contact: ACADIA Pharmaceuticals United States: Uli Hacksell, Ph.D.,CEO +1 858-558-2871. Europe: Bo-Ragnar Tolf, Ph.D., VP of Chemistry and ACADIA Pharmaceuticals Announces Retirement of Uli Hacksell, Ph.D., Chief Executive Officer Steve Davis Appointed Interim Chief Executive Officer SAN DIEGO-- ACADIA Pharmaceuticals Inc. (ACAD), a ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q1 2014 Results Earnings Conference Call May 6, 2014 5:00 PM ET Executives. Lisa Barthelemy - Director of Investor Relations. Uli Hacksell - CEO. Roger G Uli Hacksell is considered to be independent in relation to the company as well as its senior management and in relation to major shareholders.

Uli Hacksell, f 1950 Professor i organisk kemi. Chief executive officer, ACADIA Pharmaceuticals,. San Diego, CA, USA. 4. Håkan Billig, f 1955 Uli Hacksell (CEO), Linda Basse, Magnus Christensen, 1) Uli Hacksell took over as CEO on October 15, 2018.
Behålla sgi gravid

Uli has 1 job listed on their profile. See the complete profile on LinkedIn and discover Uli’s connections ACADIA Pharmaceuticals Announces Retirement of Uli Hacksell, Ph.D., Chief Executive Officer Steve Davis Appointed Interim Chief Executive Officer March 11, 2015 04:02 PM Eastern Daylight Time Uli Hacksell: This page shows the track record and history of Hacksell Uli insider trades in ACADIA Pharmaceuticals, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company.

ACADIA Pharmaceuticals Inc. 2010 EQUITY INCENTIVE PLAN. 2004 EMPLOYEE STOCK PURCHASE PLAN (Full Titles of the Plans) Uli Hacksell, Ph.D. President and Chief Executive Officer .
Fakturamall mac numbers

lösa upp blodpropp
young business creatives
körförbud försäkring
bekräftelse psykologi
brodozer monster truck
begagnad musikutrustning
lk mässinteriör

Shareholders of SynAct Pharma proposes Uli Hacksell as new board member US-based ACADIA Pharmaceuticals and Cerecor, as well as his time at Astra.

(-)-OSU6162 has promise for treating Parkinson's disease, Huntington's disease and schizophrenia. Behavioral tests evaluating the locomotor 11 Mar 2015 Acadia Pharmaceuticals Inc. won't be seeking regulatory approval for nervous system disorders, said longtime Chief Executive Uli Hacksell 29 May 2015 --Uli Hacksell, PhD, Appointed Chairman of the Board of Directors-- Dr. Hacksell was most recently CEO of ACADIA Pharmaceuticals Inc. 2 Sep 2014 the urgent need for a treatment for patients with Parkinson's disease psychosis, ” said Uli Hacksell, Ph.D., Chief Executive Officer of ACADIA.

Antagningspoang tandlakarprogrammet umea
uppdragsfullmakt

Affiliation 1 ACADIA Pharmaceuticals Inc., 11085 Torreyana Road, Ste. 100, San Diego, CA, 92121, USA, uli@acadia-pharm.com.

11, 2015-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and related central nervous system disorders, today announced that Uli Hacksell, Ph.D., has retired as ACADIA’s Chief Executive Officer and as a member of 2021-04-07 · Uli Hacksells CV inkluderar 30 års arbete inom farmaceutisk industri och bioteknikbolag, däribland som vd för San Diego-baserade Acadia Pharmaceuticals. Uli Hacksell har styrelseuppdrag i Medivir, Index Pharmaceuticals Holding, Active Biotech och Synact Pharma. Dr Uli Hacksell (1950) has over 20 years of international management experience from both large pharmaceutical and biotech companies.

Affiliation 1 ACADIA Pharmaceuticals Inc., 11085 Torreyana Road, Ste. 100, San Diego, CA, 92121, USA, uli@acadia-pharm.com.

Uli Hacksell har styrelseuppdrag i Medivir, Index Pharmaceuticals 2015年3月11日 Separately, Acadia said Uli Hacksell had retired as chief executive and board member, and Chief Financial Officer Steve Davis would take over ACADIA PHARMACEUTICALS 2014 ANNUAL REPORT→ After 16 years of service, Uli Hacksell, Ph.D. retired in March 2015. Under Uli's leadership as. articles by 'Uli Hacksell' · Hacksell U, ACADIA Pharmaceuticals Inc., San Diego, CA 92131, USA. fpiu@acadia-pharm.com.

Född: Titel: Som vd för ACADIA Pharmaceuticals ledde Hacksell utvecklingen från privat start-up företag till publikt mångmiljardbolag. View Uli Hacksell’s profile on LinkedIn, the world's largest professional community. Uli has 1 job listed on their profile. See the complete profile on LinkedIn and discover Uli’s connections SAN DIEGO -- (BUSINESS WIRE)--Mar. 11, 2015-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and related central nervous system disorders, today announced that Uli Hacksell, Ph.D., has retired as ACADIA’s Chief Executive Officer and as a member of the Board of Directors, effective today. Uli Hacksell is Former President/CEO at Medivir AB. See Uli Hacksell's compensation, career history, education, & memberships.